Signal active
Organization
Contact Information
Overview
Sanity Group is a European cannabis company focusing on health, wellbeing, and scientific research. The company's mission is to improve people’s quality of life through the use of cannabinoids, thus developing consumer products based on non-psychoactive cannabinoids.
It was founded in 2018 and is headquartered in Berlin, Germany.
About
Biotechnology, Health Care, Medical, Wellness, Cannabis
2018
101-250
Headquarters locations
Europe
Social
N/A
Profile Resume
Sanity Group headquartered in Europe, operates in the Biotechnology, Health Care, Medical, Wellness, Cannabis sector. The company focuses on Biotechnology and has secured $24.2B in funding across 180 round(s). With a team of 101-250 employees, Sanity Group is actively contributing to advancements in Biotechnology. Their latest funding round, Secondary Market - Sanity Group, raised $2.7M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
9
1
0
$134.7M
Details
5
Sanity Group has raised a total of $134.7M in funding over 5 rounds.
Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
---|---|---|---|---|
2020 | Early Stage Venture | 22.0M | ||
2021 | Early Stage Venture | 44.2M | ||
2021 | Early Stage Venture | 3.5M | ||
2022 | Early Stage Venture | 37.6M |
Investors
Sanity Group is funded by 45 investors.
Investor Name | Lead Investor | Funding Round | Partners |
---|---|---|---|
Sanity Group | - | FUNDING ROUND - Sanity Group | 12.3M |
OrganiGram | - | FUNDING ROUND - OrganiGram | 12.3M |
Sanity Group | - | FUNDING ROUND - Sanity Group | 2.7M |
OrganiGram | - | FUNDING ROUND - OrganiGram | 2.7M |
Recent Activity
There is no recent news or activity for this profile.